174 related articles for article (PubMed ID: 25931145)
1. JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter.
Wagner AH; Conzelmann M; Fitzer F; Giese T; Gülow K; Falk CS; Krämer OH; Dietrich S; Hecker M; Luft T
Biochem Pharmacol; 2015 Jul; 96(1):52-64. PubMed ID: 25931145
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production.
Conzelmann M; Wagner AH; Hildebrandt A; Rodionova E; Hess M; Zota A; Giese T; Falk CS; Ho AD; Dreger P; Hecker M; Luft T
Biochem Pharmacol; 2010 Dec; 80(12):2074-86. PubMed ID: 20709027
[TBL] [Abstract][Full Text] [Related]
3. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway.
Liu WH; Liu JJ; Wu J; Zhang LL; Liu F; Yin L; Zhang MM; Yu B
PLoS One; 2013; 8(1):e55487. PubMed ID: 23383203
[TBL] [Abstract][Full Text] [Related]
5. The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression.
Hou T; Ray S; Brasier AR
J Biol Chem; 2007 Dec; 282(51):37091-102. PubMed ID: 17956865
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription (STAT) 1 and STAT3 are expressed in the human ovary and have Janus kinase 1-independent functions in the COV434 human granulosa cell line.
Frost ER; Ford EA; Peters AE; Reed NL; McLaughlin EA; Baker MA; Lovell-Badge R; Sutherland JM
Reprod Fertil Dev; 2020 Aug; 32(12):1027-1039. PubMed ID: 32758351
[TBL] [Abstract][Full Text] [Related]
7. RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes.
Nowak DE; Tian B; Jamaluddin M; Boldogh I; Vergara LA; Choudhary S; Brasier AR
Mol Cell Biol; 2008 Jun; 28(11):3623-38. PubMed ID: 18362169
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
[TBL] [Abstract][Full Text] [Related]
9. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
10. Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes.
Kurdi M; Sivakumaran V; Duhé RJ; Aon MA; Paolocci N; Booz GW
Int J Biochem Cell Biol; 2012 Dec; 44(12):2106-15. PubMed ID: 22939972
[TBL] [Abstract][Full Text] [Related]
11. Transcription Elongation Factor P-TEFb Is Involved in IL-17F Signaling in Airway Smooth Muscle Cells.
Nakajima M; Kawaguchi M; Matsuyama M; Ota K; Fujita J; Matsukura S; Huang SK; Morishima Y; Ishii Y; Satoh H; Sakamoto T; Hizawa N
Int Arch Allergy Immunol; 2018; 176(2):83-90. PubMed ID: 29649811
[TBL] [Abstract][Full Text] [Related]
12. JAK/STAT regulation of Aspergillus fumigatus corneal infections and IL-6/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity.
Taylor PR; Roy S; Meszaros EC; Sun Y; Howell SJ; Malemud CJ; Pearlman E
J Leukoc Biol; 2016 Jul; 100(1):213-22. PubMed ID: 27034404
[TBL] [Abstract][Full Text] [Related]
13. Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/β-catenin signaling and attenuates hyperproliferation in gastric epithelial cells.
Park B; Lim JW; Kim H
Nutr Res; 2019 Oct; 70():70-81. PubMed ID: 30098838
[TBL] [Abstract][Full Text] [Related]
14. The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.
Hermans MAW; Schrijver B; van Holten-Neelen CCPA; Gerth van Wijk R; van Hagen PM; van Daele PLA; Dik WA
Clin Exp Allergy; 2018 Nov; 48(11):1412-1420. PubMed ID: 29939445
[TBL] [Abstract][Full Text] [Related]
15. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells.
Campia I; Buondonno I; Castella B; Rolando B; Kopecka J; Gazzano E; Ghigo D; Riganti C
PLoS One; 2015; 10(5):e0126159. PubMed ID: 25955018
[TBL] [Abstract][Full Text] [Related]
16. Baicalein reduces lipopolysaccharide-induced inflammation via suppressing JAK/STATs activation and ROS production.
Qi Z; Yin F; Lu L; Shen L; Qi S; Lan L; Luo L; Yin Z
Inflamm Res; 2013 Sep; 62(9):845-55. PubMed ID: 23743662
[TBL] [Abstract][Full Text] [Related]
17. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
Kurdi M; Booz GW
J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
19. The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.
Albert TK; Antrecht C; Kremmer E; Meisterernst M
PLoS One; 2016; 11(1):e0146648. PubMed ID: 26745862
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation.
Gu L; Talati P; Vogiatzi P; Romero-Weaver AL; Abdulghani J; Liao Z; Leiby B; Hoang DT; Mirtti T; Alanen K; Zinda M; Huszar D; Nevalainen MT
Mol Cancer Ther; 2014 May; 13(5):1246-58. PubMed ID: 24577942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
